Document Type : Original Article(s)

Authors

1 Department of Radiation Oncology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

2 Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford University, Stanford, USA

Abstract

Background: Adenoid cystic carcinomas is a rare tumor occurring in major salivary glands. Despite definitive treatment, these aggressive cancers often recur and metastasize with no known effective chemotherapy regimen. The present study aimed to evaluate the recurrence and survival rates of head-and-neck adenoid cystic carcinoma and assess the prognostic factors related to the patients' local recurrence and survival.
Method: A retrospective study was conducted on 54 patients with adenoid cystic carcinoma. Demographic data, operative factors of patients before, during, and after surgery were reviewed and finally calculated using the Kaplan-Meier method.
Results: Among the 54 patients, 61.1% were female, and 38.9% were male with an average age of 46.00 ± 14.52 years. The survival rate at 12, 24, 36, 60, 84, 100 and 120 months post-surgery were 100, 93.3, 84.4, 48.9, 24.4, 20.0 and 13.3%, respectively. Both the marital status (P = 0.002) and the type of surgery (P = 0.045) were significantly related to the overall survival of the patients, and the local recurrence significantly correlated with overall survival (P = 0.027).
Conclusion: According to the findings, marital status, type of surgery, metastases, histological staging, and local recurrence rate were related to the overall survival of the patients. Hence, it is of utmost importance to pay attention to these factors in health centers. It is recommended to opt for case-control and prospective studies with more samples for further investigation in the future.

Keywords

How to cite this article:

Farhan F, Kazemian A, Jafari F, Karimi Hosseini D, Samiee F, Esmati E, et al. Local recurrence and survival in patients with adenoid cystic carcinoma of head and neck. Middle East J Cancer. 2022;13(3):507-14. doi: 10.30476/mejc.2022.87963.1454.

  1. Pinakapani R, Chaitanya NC, Lavanya R, Yarram S, Boringi M, Waghray S. Adenoid cystic carcinoma of the head and neck? literature review. Qual Prim Care. 2015;23(5):309-14.
  2. Dillon PM, Chakraborty S, Moskaluk CA, Joshi PJ, Thomas CY. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials. Head Neck. 2016;38(4):620-7. doi: 10.1002/hed.23925.
  3. Hu MM, Hu Y, He JB, Li BL. Primary adenoid cystic carcinoma of the lung: Clinicopathological features, treatment and results. Oncol Lett. 2015;9(3):1475-81. doi: 10.3892/ol.2015.2859.
  4. Dantas AN, Morais EF, Macedo RA, Tinôco JM, Morais Mde L. Clinicopathological characteristics and perineural invasion in adenoid cystic carcinoma: a systematic review. Braz J Otorhinolaryngol. 2015;81(3):329-35. doi: 10.1016/j.bjorl.2014.07.016.
  5. Rhee CS, Won TB, Lee CH, Min YG, Sung MW, Kim KH, et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope. 2006;116(6):982-6. doi: 10.1097/01.mlg.0000216900.03188.48.
  6. Bhayani MK, Yener M, El-Naggar A, Garden A, Hanna EY, Weber RS, et al. Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer [Internet]. 2012 Jun 1 [cited 2021 Mar 22];118(11):2872–8. Available from: https://pubmed.ncbi.nlm.nih.gov/22020577/
  7. Sato K, Ueda Y, Sakurai A, Ishikawa Y, Kaji S, Nojima T, et al. Adenoid cystic carcinoma of the maxillary sinus with gradual histologic transformation to high-grade adenocarcinoma: a comparative report with dedifferentiated carcinoma. Virchows Arch. 2006;448(2):204-8. doi: 10.1007/s00428-005-0054-8.
  8. Ko JJ, Siever JE, Hao D, Simpson R, Lau HY. Adenoid cystic carcinoma of head and neck: clinical predictors of outcome from a Canadian centre. Curr Oncol. 2016;23(1):26-33. doi: 10.3747/co.23.2898.
  9. van Weert S, Bloemena E, van der Waal I, de Bree R, Rietveld DH, Kuik JD, et al. Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period. Oral Oncol. 2013;49(8):824-9. doi: 10.1016/j.oraloncology.2013.05.004.
  10. Li N, Xu L, Zhao H, El-Naggar AK, Sturgis EM. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry. Cancer. 2012;118(16):3945-53. doi: 10.1002/cncr.26740.
  11. C Coca-Pelaz A, Rodrigo JP, Bradley PJ, Vander Poorten V, Triantafyllou A, Hunt JL, et al. Adenoid cystic carcinoma of the head and neck--An update. Oral Oncol. 2015;51(7):652-61. doi: 10.1016/j.oraloncology.2015.04.005.
  12. Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999;125(2):149-52. doi: 10.1001/archotol.125.2.149.
  13. Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck--a 20 years experience. Int J Oral Maxillofac Surg. 2004;33(1):25-31. doi: 10.1054/ijom.2003.0448.
  14. Ju J, Li Y, Chai J, Ma C, Ni Q, Shen Z, et al. The role of perineural invasion on head and neck adenoid cystic carcinoma prognosis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(6):691-701. doi: 10.1016/j.oooo.2016.08.008.
  15. He S, Li P, Zhong Q, Hou L, Yu Z, Huang Z, et al. Clinicopathologic and prognostic factors in adenoid cystic carcinoma of head and neck minor salivary glands: A clinical analysis of 130 cases. Am J Otolaryngol. 2017;38(2):157-62. doi: 10.1016/j.amjoto.2016.11.014.
  16. Gaissert HA, Grillo HC, Shadmehr MB, Wright CD, Gokhale M, Wain JC, et al. Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina. Ann Thorac Surg. 2004;78(6):1889-96; discussion 1896-7. doi: 10.1016/j.athoracsur.2004.05.064.
  17. Rautray S, Sahoo T, Das SK, Majumdar S, Parida D. Primary Adenoid Cystic Carcinoma of Head and Neck: Its Prognosis and Management-A Retrospective Analysis from a Tertiary Care Center [Intermet]. Semantic Scholar; 2016. Available from: https://www.semanticscholar.org/paper/Primary-Adenoid-Cystic-Carcinoma-of-Head-and-Neck%3A-Rautray-Sahoo/8ebc38680842dd45c0d7e8b3a49eea56c7394709  
  18. Friedrich RE, Bleckmann V. Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients. Anticancer Res. 2003;23(2A):931-40.
  19. Gondivkar SM, Gadbail AR, Chole R, Parikh RV. Adenoid cystic carcinoma: a rare clinical entity and literature review. Oral Oncol. 2011;47(4):231-6. doi: 10.1016/j.oraloncology.2011.01.009.
  20. Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol. 2011;34(1):76-81. doi: 10.1097/COC.0b013e3181d26d45.
  21. Monteiro D, Lino J, Bernardo T, Fernandes J, Monteiro E. Adenoid Cystic carcinoma of the head and neck: Epidemiology and predictors of prognosis. Int J Otolaryngol Head Neck Surg. 2013;2(5):165-73. doi: 10.4236/ijohns.2013.25036.
  22. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer. 2005;103(12):2544-50. doi: 10.1002/cncr.21083.
  23. Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, Peters LJ. Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer. 1994;73(10):2563-9. doi: 10.1002/1097-0142(19940515)73:10<2563::aid-cncr2820731018>3.0.co;2-x.